Christina DiLauro Abaya

A Phase I Study of Samarium Lexidronam/Bortezomib Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma

James R. Berenson, Ori Yellin, Ravi Patel et al. · Clinical Cancer Research · 2009 · 45 citations

Medicine, Hematology, Pharmacology +14

Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well‐tolerated frontline regimen

James R. Berenson, Ori Yellin, Donald Woytowitz et al. · European Journal Of Haematology · 2009 · 26 citations

Medicine, Hematology, Pharmacotherapy +15

Pembrolizumab (pembro) with paclitaxel (taxol) or capecitabine (cape) as early treatment of metastatic triple-negative breast cancer (mTNBC).

David B. Page, Brie Chun, Joanna Pucilowska et al. · Journal of Clinical Oncology · 2019 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +16

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

DB Page, Joanna Pucilowska, Laura Bennetts et al. · Cancer Research · 2019 · 11 citations

Medicine, Oncology, Pharmacology +17

Short Communication: Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery

David Pitrak, Richard Novák, Randee Estes et al. · AIDS Research and Human Retroviruses · 2014 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17